Hospital JP Garrahan   Report issue

Academic/Hospital Phase 3 Phase 4
Founded: Buenos Aires Argentina (1987)

Organization Overview

First Clinical Trial
2004
NCT00426101
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Hospital JP Garrahan

Active Ingredients

Drugs in Phase 4 Trials (1)

azithromycin (zithromax) (1 trial)

Drugs in Phase 3 Trials (5)

cyclosporine (sandimmune) (1 trial)

etoposide (vepesid) (1 trial)

stem cells (1 trial)

topotecan (hycamtin) (2 trials)

urea (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Lymphohistiocytosis, Hemophagocytic (Phase 3)

Retinoblastoma (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 4
  • # of Trial APIs: 6